Idexx Laboratories IDXX CAG — Gross Profit
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Idexx Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GrossProfit.
The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Idexx Laboratories's cag — gross profit.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Idexx Laboratories's CAG — gross profit?
- Idexx Laboratories (IDXX) reported CAG — gross profit of $667.51M in Q1 2026.
- How has Idexx Laboratories's CAG — gross profit changed year-over-year?
- Idexx Laboratories's CAG — gross profit increased by 16.1% year-over-year, from $574.82M to $667.51M.
- What is the long-term trend for Idexx Laboratories's CAG — gross profit?
- Over 3 years (2022 to 2025), Idexx Laboratories's CAG — gross profit has grown at a 10.7% compound annual growth rate (CAGR), from $1.81B to $2.45B.
- What does CAG — gross profit mean?
- This metric is calculated as the total revenue of the Companion Animal Group segment minus its direct cost of revenue. It represents the fundamental profitability of the segment before accounting for operating expenses like research and development or marketing. It is a key indicator of the pricing power and manufacturing efficiency of the company's core diagnostic business.